CAB39 K196 Decrotonylation Drives Psoriasis Pathogenesis by Modulating Keratinocyte Proliferation and Glycolysis
Journal of Cellular Physiology · 2026-09 · 241 (9)
DOI: 10.1002/jcp.70224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 11.09.2026. Verfasst von Huifang Liang und 3 weiteren Autor:innen. Beteiligte Einrichtung: ShanXi Key Laboratory of Stem Cells for Immunological Dermatosis, State Key Breeding Laboratory of Stem Cells for Immunological Dermatosis, Institute…. Hauptthemen laut MEDLINE: Psoriasis, Keratinocytes, Cell Proliferation, Glycolysis. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Provincial Natural Sience Foundation of China.
Abstract (Originalsprache)
Psoriasis is a chronic and recurrent inflammatory dermatosis characterized by dysregulated keratinocyte proliferation. Calcium‐binding protein 39 (CAB39), a critical regulatory scaffold for Sterile 20 kinase, has been implicated in multiple diseases, but its role and regulatory mechanisms in psoriasis remain unclear. Here, we found that CAB39 was significantly upregulated in psoriatic lesions, and CAB39 knockdown inhibited keratinocyte proliferation and attenuated psoriasis progression. Further investigations revealed that CAB39 crotonylation at lysine 196 was reduced in psoriatic lesions. Functional analyses in normal human epidermal keratinocytes (NHEKs) showed that the crotonylation‐deficient CAB39 K196A mutant significantly promoted keratinocyte hyperproliferation and glycolytic remodeling. Dysregulation of modifying enzymes, including downregulated CBP and upregulated HDAC2/3, drives CAB39 K196 decrotonylation in psoriasis. Mechanistically, CAB39 K196 decrotonylation weakens its binding affinity to STRAD (STE20‐related adaptor), disrupts the stability of the CAB39‐STRAD‐LKB1 (liver kinase B1) complex, and inhibits the LKB1/AMPK signaling pathway. Concurrently, decrotonylated CAB39 promotes phosphatidic acid (PA, a lipid second messenger) synthesis, activating the pro‐proliferative PA/MAPK/mTOR signaling cascade. Our findings uncover a novel pathogenic mechanism in psoriasis, wherein CAB39 K196 decrotonylation drives keratinocyte dysfunction, and expand our understanding of non‐histone crotonylation in inflammatory skin diseases. Importantly, targeting the CBP/HDAC2/3‐CAB39 crotonylation axis may represent a potential therapeutic strategy for psoriasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ShanXi Key Laboratory of Stem Cells for Immunological Dermatosis, State Key Breeding Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan City Central Hospital, Taiyuan, China.
- Department of Dermatology, The Second People's Hospital of Changzhi, Changzhi, China.
ORCID-Profile: Huifang Liang, Junqin Li, Kaiming Zhang
Förderung
- National Natural Science Foundation of China
- Provincial Natural Sience Foundation of China
Zitieren
APA
Liang, H., Li, J., Jing, W., & Zhang, K. (2026). CAB39 K196 Decrotonylation Drives Psoriasis Pathogenesis by Modulating Keratinocyte Proliferation and Glycolysis. Journal of Cellular Physiology, 241(9). https://doi.org/10.1002/jcp.70224
Vancouver
Liang H, Li J, Jing W, Zhang K. CAB39 K196 Decrotonylation Drives Psoriasis Pathogenesis by Modulating Keratinocyte Proliferation and Glycolysis. Journal of Cellular Physiology. 2026;241(9). doi:10.1002/jcp.70224
BibTeX
@article{Liang2026,
author = {Liang, Huifang and Li, Junqin and Jing, Weixia and Zhang, Kaiming},
title = {CAB39 K196 Decrotonylation Drives Psoriasis Pathogenesis by Modulating Keratinocyte Proliferation and Glycolysis},
journal = {Journal of Cellular Physiology},
year = {2026},
volume = {241},
number = {9},
doi = {10.1002/jcp.70224}
}
EUVIMED